CIVIS announces the opening of the registration for the CIVIS course “Drug design and discovery”. The programme will take place in a blended format between March and June 2022 & 4 – 8 July 2022.
This CIVIS course is organised as follows:
- Online lectures will take place once a week, every Friday for 3 hours, from March to June 2022.
- A summer school will be held from 4 to 8 July 2022 in Athens, Greece, hosted by the National and Kapodistrian University of Athens.
20 CIVIS scholarships will be offered to support selected students’ travel and subsistence expenses.
The short programme “Drug design and discovery” explores the various processes of design discovery and development of new drugs, with emphasis on the methodologies of rational design of low molecular weight bioactive molecules.
The Drug Design and Discovery course will provide insights on different aspects of the drug discovery process, mainly focusing on the study of the interaction between pharmacologically interesting targets and small molecules, either by biophysical methods or computational chemistry approaches.
Through lectures and laboratory exercises, students will be introduced to the different scientific approaches applied in the successive stages of development and design of new drugs, and the role and importance of different factors to achieve the desired result.
This blended mobility course is open to Master’s and PhD students at the nine CIVIS member universities. A B2 level of English is required.
Applicants should submit their CV, a recommendation letter (click here to find a structured recommendation letter) as well as a copy of their University records, in English and in PDF format. Applications are to be sent to Emmanuel Mikros (firstname.lastname@example.org) by 24 January 2022. Selected students will be notified on 11 February 2022.
Students will be assessed based on: their performances during workshops and on the quality of their presentations.
More details about the intensive CIVIS Course “Drug design and discovery” are available on the CIVIS webpage here.
CIVIS is a European Civic University formed by the alliance of nine leading research higher education institutions across Europe: Aix-Marseille Université, National and Kapodistrian University of Athens, Universitatea din București, Université libre de Bruxelles, Universidad Autónoma de Madrid, Sapienza Università di Roma, Stockholm University, Eberhard Karls Universität Tübingen and University of Glasgow. It brings together a community of more than 450,000 students and 65,000 staff members including 30,000 academics and researchers. Recently, CIVIS was joined by Paris Lodron University of Salzburg.